Details for Patent: 8,563,027
✉ Email this page to a colleague
Which drugs does patent 8,563,027 protect, and when does it expire?
Patent 8,563,027 protects DEXTENZA and is included in one NDA.
This patent has nineteen patent family members in six countries.
Summary for Patent: 8,563,027
| Title: | Drug delivery through hydrogel plugs |
| Abstract: | An embodiment is a medical prosthesis for blocking or reducing tear flow through a punctum or canaliculus of a human eye and delivering a drug to the eye that comprises a dehydrated covalently crosslinked synthetic hydrophilic polymer hydrogel with dimensions to pass through a puncta lacrimali, with the dehydrated hydrogel absorbing physiological water to swell to at least 1 mm in cross-sectional width and conformably fit a canaliculus, with the hydrogel comprising a therapeutic agent dispersed through the hydrogel for release to an eye, with the hydrogel having a water content of at least about 50% by weight or volume when allowed to fully hydrate in vitro in physiological saline. |
| Inventor(s): | Jarrett; Peter (Lexington, MA), Bassett; Michael (Pepperell, MA), Blizzard; Charles D. (Westwood, MA), Sawhney; Amarpreet S. (Lexington, MA) |
| Assignee: | Incept, LLC (Bedford, MA) |
| Application Number: | 13/777,103 |
|
Patent Claim Types: see list of patent claims | Use; Compound; Process; Delivery; |
Drugs Protected by US Patent 8,563,027
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ocular Therapeutix | DEXTENZA | dexamethasone | INSERT;OPHTHALMIC | 208742-001 | Nov 30, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | DEXTENZA IS APPROVED FOR THE TREATMENT OF OCULAR PAIN FOLLOWING OPHTHALMIC SURGERY | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,563,027
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2010213612 | ⤷ Try a Trial | |||
| Australia | 2010246115 | ⤷ Try a Trial | |||
| Australia | 2016201869 | ⤷ Try a Trial | |||
| Australia | 2018200074 | ⤷ Try a Trial | |||
| Canada | 2750242 | ⤷ Try a Trial | |||
| Canada | 2760704 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
